Ophthalmology

Patients receiving uncomplicated phacoemulsification surgery for cataracts had greater increases in macular and choroidal thickness if they had early diabetic retinopathy without preoperative diabetic macular edema.

Children who took short-term topical atropine eye drops, 0.01% to 1.0%, had no difference in final refractive errors 10 to 20 years after treatment.

Patients with diabetic macular edema could be treated with brolucizumab with as much effectiveness as aflibercept.

Patients with retinal vein occlusion-related macular edema had a higher likelihood of blindness and low vision if they had low best-corrected visual acuity after 1 month of intravitreal treatment.

Male adolescent and young adult patients were found to have an increased risk of keratoconus if they had attention-deficit/hyperactivity disorder (ADHD), regardless of confounders.

Both the retina as a whole and separate retinal layers had a reduction in retinal thickness after the use of anti-vascular endothelial growth factor (VEGF) treatments.

Intravitreal aflibercept was used in patients with retinal vein occlusion (RVO) which led to functional and anatomic improvements in the patients after treatment.

Medicare beneficiaries in California in 2019 had multiple causes of glaucoma and primary open-angle glaucoma, indicating a need to investigate undiagnosed glaucoma.

Patients with a history of retinal artery occlusions were found to have an increased risk of myocardial infarction and death compared with patients who had cataracts.

Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island, spoke with AJMC about the safety and accessibility of lotilaner ophthalmic solution for patients with Demodex blepharitis.

Age played a part in the decrease in vision testing in adolescents, along with fewer reported tests in primary and school-based settings.

Patients with limited English proficiency (LEP) who presented for cataract surgery had a higher rate of diabetic retinopathy compared with patients with English proficiency.

Age-related macular degeneration (AMD) and impaired vision were found to be associated with choriocapillaris flow signal deficits in patients 60 years and older.

Eyes of patients with pseudophakic cystoid macular edema demonstrated greater retinal nerve fiber layer (RNFL) thickness compared with healthy eyes.

In a real-world setting, artificial intelligence (AI) proved to be effective in screening for referable diabetic retinopathy.

Researchers also suggest potential new genetic associations with macular edema, which warrant further research.

Although major gender bias on the national level was not found, differences in medical knowledge (MK) ratings could be an indicator of gender bias in ophthalmology education.

Higher-cost therapies for age-related macular edema (ARMD) were significantly more likely to be prescribed by ophthalmologists accepting manufacturer payments.

Severe and frequent ocular symptoms were more likely in adolescents and young adults who used e-cigarettes and cigarettes.

Recurrent exudations in patients with exudative age-related macular degeneration (eAMD) can be sufficiently monitored with macular thickness maps alone.

The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy.

Individuals with a higher risk of primary open-angle glaucoma (POAG) could be identified using a polygenic risk score, recent study found.

A recent study found that children who had private insurance had a higher probability of vision testing compared with uninsured and publicly insured children.

Patients with nonischemic branch retinal vein occlusion had their macular edema severity associated with leakage index.

The FDA approved the usage of Izervay (avacincaptad pegol) for the treatment of geographic atrophy secondary to age-related macular degeneration.